2011. Gefitinib: a pharmacoeconomic profile of its use in patients with Non Small Cell Lung Cancer EGFR+. Farmeconomia. Health Economics and Therapeutic Pathways. 12, 2 (Jun. 2011), 77–85. DOI:https://doi.org/10.7175/fe.v12i2.73.